Taiwan company calls for second chance for its COVID vaccine candidate

Taiwan-based United Biomedical Inc. (UBI) Asia called on the government Sunday to give its COVID-19 vaccine candidate UB-612 a second chance, after its request for emergency use authorization (EUA) was denied last week.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)